UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clonal Hematopoiesis: From Mechanisms to Clinical Intervention

Cancer discovery, 2021-12, Vol.11 (12), p.2987-2997

2021

Volltextzugriff (PDF)

Recent developments in immunotherapy of acute myeloid leukemia

Journal of hematology and oncology, 2017-07, Vol.10 (1), p.142-142, Article 142

2017

Volltextzugriff (PDF)

Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia

Nature cancer, 2020-08, Vol.1 (8), p.826-839

2020

Volltextzugriff (PDF)

Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19/CD3-bispecific T cell engager antibody blinatumomab

Journal of hematology and oncology, 2015-10, Vol.8 (1), p.111-111, Article 111

2015

Volltextzugriff (PDF)

Diagnosis of CLL revisited: increased specificity by a modified five‐marker scoring system including CD200

British journal of haematology, 2017-11, Vol.179 (3), p.480-487

2017

Volltextzugriff (PDF)

Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia

Leukemia, 2018-07, Vol.32 (7), p.1598-1608

2018

Volltextzugriff (PDF)

Data mining for mutation-specific targets in acute myeloid leukemia

Leukemia, 2019-04, Vol.33 (4), p.826-843

2019

Volltextzugriff (PDF)

RUNX1 loss renders hematopoietic and leukemic cells dependent on IL-3 and sensitive to JAK inhibition

The Journal of clinical investigation, 2023-10, Vol.133 (19)

2023

Volltextzugriff (PDF)

The TRACE-Seq method tracks recombination alleles and identifies clonal reconstitution dynamics of gene targeted human hematopoietic stem cells

Nature communications, 2021-01, Vol.12 (1), p.472-472, Article 472

2021

Volltextzugriff (PDF)

Enasidenib drives human erythroid differentiation independently of isocitrate dehydrogenase 2

The Journal of clinical investigation, 2020-04, Vol.130 (4), p.1843-1849

2020

Volltextzugriff (PDF)

A Role for Lipid Mediators in Acute Myeloid Leukemia

International journal of molecular sciences, 2019-05, Vol.20 (10), p.2425

2019

Volltextzugriff (PDF)

Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settings

Annals of hematology, 2015-10, Vol.94 (10), p.1677-1688

2015

Volltextzugriff (PDF)

Single-cell mutational profiling enhances the clinical evaluation of AML MRD

Blood advances, 2020-03, Vol.4 (5), p.943-952

2020

Volltextzugriff (PDF)

Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse

Haematologica (Roma), 2014-08, Vol.99 (8), p.1317-1325

2014

Volltextzugriff (PDF)

Response assessment in acute myeloid leukemia by flow cytometry supersedes cytomorphology at time of aplasia, amends cases without molecular residual disease marker and serves as an independent prognostic marker at time of aplasia and post-induction

Haematologica (Roma), 2019-11, Vol.104 (11), p.e510-e513

2019

Volltextzugriff (PDF)

IDH1 -Mutant Preleukemic Hematopoietic Stem Cells Can Be Eliminated by Inhibition of Oxidative Phosphorylation

Blood cancer discovery, 2024-03, Vol.5 (2), p.114-131

2024

Volltextzugriff (PDF)

Targeting CD157 in AML using a novel, Fc-engineered antibody construct

Oncotarget, 2017-05, Vol.8 (22), p.35707-35717

2017

Volltextzugriff (PDF)

Integrated multiomic approach for identification of novel immunotherapeutic targets in AML

Biomarker research, 2022-06, Vol.10 (1), p.43-13, Article 43

2022

Volltextzugriff (PDF)

The Cell Type-Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia

Blood cancer discovery, 2022-07, Vol.3 (4), p.346-367

2022

Volltextzugriff (PDF)

A New Era of Functional Experimentation in Human Hematopoiesis and Leukemia Research

Experimental hematology, 2024-10, p.104652, Article 104652

2024

Volltextzugriff (PDF)

Toll‐like receptor 7/8‐matured RNA‐transduced dendritic cells as post‐remission therapy in acute myeloid leukaemia: results of a phase I trial

Clinical & translational immunology, 2020, Vol.9 (3), p.e1117-n/a

2020

Volltextzugriff (PDF)

Quantitative Monitoring of NPM1 Mutation A Minimal Residual Disease Identifies Patients At High Risk for Relapse within the ELN Favorable Risk Group

Blood, 2012-11, Vol.120 (21), p.1404-1404

2012

Volltextzugriff (PDF)

A Combined Score of Minimal Residual Disease (MRD) Assessment by Flow Cytometry, Cytogenetic and Molecular Markers As Well As Age Predicts Outcome and Can Potentially Guide MRD-Based Therapy in Acute Myeloid Leukemia

Blood, 2011-11, Vol.118 (21), p.934-934

2011

Volltextzugriff (PDF)

Acetylsalicylic Acid Reduces the Severity of Dextran Sodium Sulfate-Induced Colitis and Increases the Formation of Anti-Inflammatory Lipid Mediators

BioMed research international, 2013-01, Vol.2013 (2013), p.1-10

2013

Volltextzugriff (PDF)

Targeting CD157 in AML using a novel, Fc-engineered antibody construct

Oncotarget, 2017-05, Vol.8 (22), p.35707-35717

2017

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Englisch
(91)
Deutsch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(33)
Humans
(23)
Hematology
(16)
Leukemia
(14)
Oncology
(14)
Immunotherapy
(10)
Mutation
(10)
Adult
(9)
Female
(9)
Male
(9)
Acute Myeloid Leukemia
(7)
Animals
(7)
Physical Sciences
(7)
Cancer
(6)
Chemistry
(6)
Leukemia, Myeloid, Acute - Drug Therapy
(6)
Middle Aged
(6)
Stem Cells
(6)
Aged
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(15)
Journal Of Visualized Experiments
(6)
Cancer Immunology Research
(4)
Experimental Hematology
(4)
Biophysical Journal
(3)
Blood Cancer Discovery
(3)
Cancer Discovery
(3)
Leukemia
(3)
The Journal Of Clinical Investigation
(3)
Analyst
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Clonal Hematopoiesis: From Mechanisms to Clinical Intervention

Recent developments in immunotherapy of acute myeloid leukemia

Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia

Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19/CD3-bispecific T cell engager antibody blinatumomab

Diagnosis of CLL revisited: increased specificity by a modified five‐marker scoring system including CD200

Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia

Data mining for mutation-specific targets in acute myeloid leukemia

RUNX1 loss renders hematopoietic and leukemic cells dependent on IL-3 and sensitive to JAK inhibition

The TRACE-Seq method tracks recombination alleles and identifies clonal reconstitution dynamics of gene targeted human hematopoietic stem cells

Enasidenib drives human erythroid differentiation independently of isocitrate dehydrogenase 2

A Role for Lipid Mediators in Acute Myeloid Leukemia

Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settings

Single-cell mutational profiling enhances the clinical evaluation of AML MRD

Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse

Response assessment in acute myeloid leukemia by flow cytometry supersedes cytomorphology at time of aplasia, amends cases without molecular residual disease marker and serves as an independent prognostic marker at time of aplasia and post-induction

IDH1 -Mutant Preleukemic Hematopoietic Stem Cells Can Be Eliminated by Inhibition of Oxidative Phosphorylation

Targeting CD157 in AML using a novel, Fc-engineered antibody construct

Integrated multiomic approach for identification of novel immunotherapeutic targets in AML

The Cell Type-Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia

A New Era of Functional Experimentation in Human Hematopoiesis and Leukemia Research

Toll‐like receptor 7/8‐matured RNA‐transduced dendritic cells as post‐remission therapy in acute myeloid leukaemia: results of a phase I trial

Quantitative Monitoring of NPM1 Mutation A Minimal Residual Disease Identifies Patients At High Risk for Relapse within the ELN Favorable Risk Group

A Combined Score of Minimal Residual Disease (MRD) Assessment by Flow Cytometry, Cytogenetic and Molecular Markers As Well As Age Predicts Outcome and Can Potentially Guide MRD-Based Therapy in Acute Myeloid Leukemia

Acetylsalicylic Acid Reduces the Severity of Dextran Sodium Sulfate-Induced Colitis and Increases the Formation of Anti-Inflammatory Lipid Mediators

Targeting CD157 in AML using a novel, Fc-engineered antibody construct

Suchergebnisse filtern